Persistence of novel human parvovirus PARV4 in liver tissue of adults

Journal of Medical Virology

Volumn 80, Issue 2, 2008, Pages 345-351

  Schneider, Beate ^a   Fryer, Jacqueline F ^b   Reber, Ulrike ^a   Fischer, Hans Peter ^a   Tolba, René H ^a   Baylis, Sally A ^b   Eis Hübinger, Anna M ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Genotypes; Human parvovirus 4; Liver; Persistence

Indexed keywords

VIRUS DNA;

ARTICLE; GENOTYPE; HUMAN; LIVER; LIVER BIOPSY; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PARVOVIRUS 4; PERSISTENT VIRUS INFECTION; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; VIRUS INFECTION;

ADULT; AGED; BONE MARROW; CLUSTER ANALYSIS; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; LIVER; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SERUM;

HUMAN PARVOVIRUS 4; PARVOVIRUS;

EID: 37549055860     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21069     Document Type: Article

References (22)

1. Cassinotti P, Burtonboy G, Fopp M, Siegl G. 1997. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 53:229-232.
2. Eis-Hübinger AM, Reber U, Abdul-Nour T, Glatzel U, Lauschke H, Pütz U. 2001. Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol 65:395-401.
3. Felsenstein J. 1981. Evolutionary trees from DNA sequences: A maximum likelihood approach. J Mol Evol 17:368-376.
4. Fryer JF, Kapoor A, Minor PD, Delwart E, Baylis SA. 2006. Novel parvovirus and related variant in human plasma. Emerg Infect Dis 12:151-154.
5. Fryer JF, Delwart E, Bernardin F, Tuke PW, Lukashov W, Baylis SA. 2007a. Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation. J Gen Virol 88:2162-2167.
6. Fryer JF, Delwart E, Hecht FM, Bernardin F, Jones MS, Shah N, Baylis SA. 2007b. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion 47:1054-1061.
7. Fryer JF, Lucas SB, Padley D, Baylis SA. 2007c. Parvoviruses PARV4/5 in hepatitis C virus-infected patient. Emerg Infect Dis 13:175-176.
8. Hall TA. 1999. Biological sequence alignment editor for Win 95/98/NT/2K/XP. http://www.mbio.ncsu.edu/BioEdit/bioedit.html; [Nucl Acids Symp Ser 1999, 41:95-98].
9. Hokynar K, Söderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio EK, Hedman K. 2002. A new parvovirus genotype persistent in human skin. Virology 302:224-228.
10. Jones MS, Kapoor A, Lukashov W, Simmonds P, Hecht F, Delwart E. 2005. New DNA viruses identified in patients with acute viral infection syndrome. J Virol 79:8230-8236.
11. Kerr JR, Cartron JP, Curran MD, Moore JE, Elliott JR, Mollan RA. 1995. A study of the role of parvovirus B19 in rheumatoid arthritis. Br J Rheumatol 34:809-813.
12. Longhi E, Bestetti G, Acquaviva V, Foschi A, Piolini R, Meroni L, Magni C, Antinori S, Parravicini C, Corbellino M. 2007. AIDS 21:1481-1483.
13. Manning A, Willey SJ, Bell JE, Simmonds P. 2007. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis 195:1345-1352.
14. Nguyen QT, Sifer C, Schneider V, Allaume X, Servant A, Bernaudin F, Auguste V, Garbarg-Chenon A. 1999. Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 37:2483-2487.
15. Nguyen QT, Wong S, Heegaard ED, Brown KE. 2002. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301:374-380.
16. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hübinger AM, Schneider B, Fischer HP, Tolba R, Vapalahti O, Vaheri A, Soderlund-Venermo M, Hedman K. 2006. Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103:7450-7453.
17. Parsyan A, Szmaragd C, Allain JP, Candotti D. 2007. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol 88:428-831.
18. Saitou N, Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425.
19. Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JF, Garbarg-Chenon A. 2002. Genetic diversity within human erythroviruses: Identification of three genotypes. J Virol 76:9124-9134.
20. Söderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. 1997. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 349:1063-1065.
21. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 1997. The ClustalX windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 24:4876-4882.
22. Wong S, Young NS, Brown KE. 2003. Prevalence of parvovirus B19 in liver tissue: No association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 187:1581-1586.